Characterization of vitreoretinal interface disorders using OCT in the interventional phase 3 trials of ocriplasmin

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 10, 2012, Pages 6504-6511

  DeCroos, Francis Char ^a,b   Toth, Cynthia A ^b   Folgar, Francisco A ^b   Pakola, Stephen ^c   Stinnett, Sandra S ^b   Heydary, Cynthia S ^b   Burns, Russell ^b   Jaffe, Glenn J ^b  

^a WILLS EYE HOSPITAL   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

^c ThromboGenics NV   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

OCRIPLASMIN; PLACEBO; PEPTIDE FRAGMENT; PLASMIN;

ARTICLE; B SCAN; DRUG EFFICACY; EPIRETINAL MEMBRANE; FOLLOW UP; HUMAN; INTERVENTION STUDY; MACULAR THICKNESS; MAJOR CLINICAL STUDY; MORPHOLOGY; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RETINA FOVEA; VITREORETINAL INTERFACE DISORDER; VITREORETINOPATHY; ADULT; AGED; CELL ADHESION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; RETINA; RETINA TEAR; STANDARD; VITREOUS BODY; VITREOUS BODY DETACHMENT;

ADULT; AGED; CELL ADHESION; FEMALE; FIBRINOLYSIN; FOVEA CENTRALIS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; RETINA; RETINAL PERFORATIONS; TOMOGRAPHY, OPTICAL COHERENCE; VITREOUS BODY; VITREOUS DETACHMENT;

EID: 84871879271     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10370     Document Type: Article

References (31)

1. Kohno T, Sorgente N, Ishibashi T, et al. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci. 1987;28:506-514.
2. Russell SR, Shepherd JD, Hageman GS. Distribution of glycoconjugates in the human retinal internal limiting membrane. Invest Ophthalmol Vis Sci. 1991;32:1986-1995.
3. Chen W, Mo W, Sun K, Huang X, Zhang YL, Song HY. Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy. Curr Eye Res. 2009;34:1057-1064.
4. Benz MS, Packo KH, Gonzalez V, et al. A placebo-controlled trial of microplasmin intravitreous injection to facilitate posterior vitreous detachment before vitrectomy. Ophthalmology. 117:791-797.
5. de Smet MD, Gandorfer A, Stalmans P, et al. Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial. Ophthalmology. 2009;116:1349-1355.
6. de Smet MD, Valmaggia C, Zarranz-Ventura J, Willekens B. Microplasmin: ex vivo characterization of its activity in porcine vitreous. Invest Ophthalmol Vis Sci. 2009;50:814-819.
7. Gandorfer A, Rohleder M, Sethi C, et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci. 2004;45:641-647.
8. Koizumi H, Spaide RF, Fisher YL, Freund KB, Klancnik JM Jr, Yannuzzi LA. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;145: 509-517.
9. Gallemore RP, Jumper JM, McCuen BW 2nd, Jaffe GJ, Postel EA, Toth CA. Diagnosis of vitreoretinal adhesions in macular disease with optical coherence tomography. Retina. 2000;20: 115-120.
10. Hee MR, Puliafito CA, Wong C, et al. Optical coherence tomography of macular holes. Ophthalmology. 1995;102:748-756.
11. Jumper JM, Gallemore RP, McCuen BW 2nd, Toth CA. Features of macular hole closure in the early postoperative period using optical coherence tomography. Retina. 2000;20:232-237.
12. Sonmez K, Capone A Jr, Trese MT, Williams GA. Vitreomacular traction syndrome: impact of anatomical configuration on anatomical and visual outcomes. Retina. 2008;28:1207-1214.
13. Massin P, Duguid G, Erginay A, Haouchine B, Gaudric A. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol. 2003; 135:169-177.
14. Kaiser PK, Riemann CD, Sears JE, Lewis H. Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol. 2001;131:44-49.
15. Benhamou N, Massin P, Haouchine B, Erginay A, Gaudric A. Macular retinoschisis in highly myopic eyes. Am J Ophthalmol. 2002;133:794-800.
16. Johnson MW. Posterior vitreous detachment: evolution and complications of its early stages. Am J Ophthalmol. 149:371-382.
17. Krebs I, Brannath W, Glittenberg C, Zeller F, Sebag J, Binder S. Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am J Ophthalmol. 2007;144:741-746.
18. Mojana F, Cheng L, Bartsch DU, et al. The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol. 2008;146:218-227.
19. Uchino E, Uemura A, Ohba N. Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography. Arch Ophthalmol. 2001;119:1475-1479.
20. Johnson MW. Perifoveal vitreous detachment and its macular complications. Trans Am Ophthalmol Soc. 2005;103:537-567.
21. Stalmans P. Microplasmin to treat vitreomacular traction: results of the MIVI-007 phase III clinical trial. Presented at: 10th Euretina Congress; September 4, 2010; Paris, France.
22. Peto T. Reading centers of fundus imaging. J Ophthalmic Photog. 2010;32:47-49.
23. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37-46.
24. Michalewska Z, Michalewski J, Sikorski BL, et al. A study of macular hole formation by serial spectral optical coherence tomography. Clin Experiment Ophthalmol. 2009;37:373-383.
25. Takahashi A, Nagaoka T, Ishiko S, Kameyama D, Yoshida A. Foveal anatomic changes in a progressing stage 1 macular hole documented by spectral-domain optical coherence tomography. Ophthalmology. 117:806-810.
26. Krebs I, Hagen S, Brannath W, et al. Repeatability and reproducibility of retinal thickness measurements by optical coherence tomography in age-related macular degeneration. Ophthalmology. 2010;117:1577-1584.
27. Domalpally A, Blodi BA, Scott IU, et al. The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4. Arch Ophthalmol. 2009;127:1461-1467.
28. Lee SJ, Koh HJ. Effects of vitreomacular adhesion on antivascular endothelial growth factor treatment for exudative agerelated macular degeneration. Ophthalmology. 2011;118:101-110.
29. Krebs I, Hagen S, Brannath W, et al. Repeatability and reproducibility of retinal thickness measurements by optical coherence tomography in age-related macular degeneration. Ophthalmology. 2010;117:1577-1584.
30. Zhang N, Hoffmeyer GC, Young ES, et al. Optical coherence tomography reader agreement in neovascular age-related macular degeneration. Am J Ophthalmol. 2007;144:37-44.
31. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:786-806.